How to Choose a Mycotoxin Test: What Actually Matters

Choosing a mycotoxin test is not a matter of finding one permanent ‘best laboratory’. Testing platforms change. Panels are revised. New analytical approaches become available, prices move, and a test that was the most useful option two years ago may not be the most useful option for the person in front of me today.

I therefore review the available testing rather than remaining loyal to one company simply because I have used it before. My aim is to obtain the most clinically useful information at a reasonable cost—and to understand exactly what the result can and cannot tell us.

Begin with the clinical question

A mycotoxin test should answer a question raised by the person’s timeline. That might include health changes after moving home, water damage, time in a damp building, occupational exposure, a multisystem decline or an unexplained change in a complex fertility case.

Testing without this context can produce a report but not necessarily a useful decision. Before choosing a panel, I want to know:

• what exposure is suspected and when it may have occurred;
• whether exposure may still be continuing;
• which symptoms or fertility changes followed;
• what has already been investigated;
• whether the partner shared the same environment;
• and what we will do differently if the test is positive, negative or incomplete.

Parent mycotoxins and their metabolites

One of the first principles I consider is whether the panel looks only for selected parent mycotoxins or whether it also considers relevant metabolites.

The body normally transforms and excretes compounds. A urine test that measures only a parent compound may therefore show only one part of that process. Metabolite coverage can give us additional information about what has been processed and excreted, provided the laboratory can explain what it measures and how those findings should be interpreted.

This does not mean that the panel with the longest list is automatically better. I want to understand why each group is included, what has changed when a panel is redesigned and whether the analytical explanation is clinically convincing.

What I compare between tests

When I review a testing option, I look beyond the sample report and ask:

1. Which mycotoxin groups are measured? The panel needs meaningful coverage rather than a collection of familiar names.
2. Are metabolites included? If so, I want to know which ones and why they add useful information.
3. What analytical method is used? Sensitivity, specificity, detection limits, quality controls and the way results are quantified matter more than a polished graphic.
4. How transparent is the laboratory? A laboratory should be able to explain additions, omissions and changes to its panel.
5. Can the result be interpreted clinically? The report must be connected to exposure, symptoms, treatment history and the next decision.
6. Is the cost proportionate? A less expensive test is valuable when it answers the required question. A cheaper incomplete test may simply lead to another test later.
7. What practical support is available? Sample instructions, result clarification and reliable professional communication affect the usefulness of the investigation.

A comprehensive panel is not the same as a complete assessment

A laboratory can identify a wide range of compounds and still leave important clinical questions unanswered. The report does not tell us automatically where the exposure occurred, whether it is ongoing, why one person became unwell while another did not, or whether the finding explains a fertility problem.

The result must be placed alongside the building and occupational history, food exposure, symptoms, gut and bowel function, glutathione capacity, immune and metabolic health, current medication and supplements, fertility treatment and the health of the partner.

A urine result is a sample of excretion at a particular time. It is not a standalone measure of every mycotoxin stored in the body, and a negative result does not resolve every exposure question if the clinical history remains convincing.

Preparing for the test with glutathione

I recommend preparing for urine mycotoxin testing with glutathione. Preparation can help us obtain a more clinically useful picture of what the body is able to mobilise and excrete.

The dosage must be decided individually. So must the form, duration and timing before collection. I do not use one standard dose for everyone because tolerance, current symptoms, bowel function, medication, pregnancy or fertility-treatment timing and previous reactions all affect the protocol.

The purpose is not to provoke the strongest possible reaction or manufacture a dramatic test result. It is to prepare the person safely enough for the sample to answer the clinical question. Do not copy a high-dose preparation protocol from the internet; use the instructions selected for your health and fertility situation.

Why I keep reviewing laboratories

Established laboratories may have invested heavily in a particular testing model. Newer platforms may be more willing to introduce different compounds or technologies. Neither position automatically makes a test better.

A long-established test may have useful consistency and accumulated experience. A newer test may offer broader metabolite coverage, improved methods or a more reasonable price. I compare the actual panel and analytical rationale rather than choosing on company size, familiarity or novelty alone.

This is the same principle I use elsewhere in functional testing. A stool test, for example, may offer excellent microbial sequencing while omitting the digestive, inflammatory or functional markers needed for the clinical question. Technology is useful only when it supplies the information required for the decision.

What this means in fertility work

Mycotoxin testing is not a routine fertility test for everyone. I consider it when the exposure and health timeline creates a credible unanswered question, particularly in complex fertility, recurrent loss, implantation difficulty, unexplained multisystem symptoms or fertility over 40 where time should not be lost repeating incomplete investigations.

Both partners should participate in a complex fertility investigation. If both lived or worked in the same building, their exposures may overlap while their symptoms and ability to process those exposures may differ. The test choice and preparation therefore remain individual even within a couple.

You can also read Food Mycotoxins and Damp Buildings: Why Food Is Rarely the Whole Story for the distinction between dietary and building exposure.

Before booking, you may want to familiarise yourself with my methodology. If you are considering mycotoxin testing and need to decide whether it belongs in your fertility investigation, you can book an Introductory Fertility Review. I will review the exposure and fertility timeline, decide which test characteristics matter in your case and provide an individual preparation protocol where testing is appropriate.

This article is educational and does not replace medical advice, diagnosis or treatment. Diagnosis and any prescribed treatment should be provided by a qualified medical professional.